SLAMF7 and plasma cell myeloma: However, a major limitation of this strategy lies in the fact that CS1 is also expressed on normal lymphocytes and NK cells, which may lead to fratricide both in vitro and in vivo, thereby reducing NK cell viability and compromising their anti-myeloma activity.